COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
Aug 12, 2022
The Food and Drug Administration yesterday advised people who get a negative result from an at-home COVID-19 antigen test to test themselves again after 48 hours to reduce the risk of missing an infection and spreading the virus to others.
Aug 11, 2022
The CDC released updated guidance to help people protect themselves and others if they are exposed to, sick or test positive for COVID-19.
Jul 8, 2022
The FDA granted full approval of Pfizer’s COVID-19 vaccine for young teens, covering the age group spanning 12 to 15 years old
Jul 6, 2022
The FDA authorized state-licensed pharmacists to prescribe Paxlovid to patients as a treatment for those at high risk of severe COVID-19.
Hospitals and Health Systems Are Working to Implement Price Transparency Policies and Help Patients Understand Costs
Jun 16, 2022
The AHA is supporting this activity by highlighting tools that aid patients and align with the new federal price transparency policy.
Jun 10, 2022
An initial 10 million doses of COVID-19 vaccine are available for children under age 5 if the Food and Drug Administration authorizes and the Centers for Disease Control and Prevention recommends the Pfizer and Moderna vaccines for children in this age group, Assistant Secretary for Preparedness…
Apr 6, 2022
The Centers for Medicare & Medicaid Services (CMS) today released updated guidance for compliance with the agency’s COVID-19 vaccination requirement for health care staff.
Mar 28, 2022
AHA, hospital groups ask U.S. Department of Health and Human Services Secretary, Xavier Becerra, to renew the COVID-19 public health emergency (PHE).
Mar 25, 2022
The Centers for Disease Control and Prevention yesterday broadened its masking guidance, enabling visitors of health care facilities to wear N95 masks.
Mar 16, 2022
Pfizer asked the Food and Drug Administration to authorize a second booster dose of its COVID-19 vaccine for adults age 65 and older who received an initial booster of any authorized or approved COVID-19 vaccine, based on data from Israel showing the additional booster reduced infections and severe…